Literature DB >> 21814887

An unusual association of neuroendocrine tumors in MEN 1A.

Mariela Varsavsky1, Rebeca Reyes-García, Guillermo Alonso García, Manuel Muñoz-Torres.   

Abstract

Multiple Endocrine Neoplasia type 1 is an autonomic dominant disease with a high degree of penetrance. It is characterized by combinations of over 20 different endocrine and nonendocrine tumors. A 25-year-old woman was referred for 1 year-evolution amenorrhea and bilateral galactorrhea. She also had fasting hypoglycaemia and hypercalcemia, and she was diagnosed of Multiple Endocrine Neoplasia type 1A. Resection of three parathyroid glands was performed showing hyperplasia of principal cells. Post-parathyroidectomy serum levels of calcium and intact PTH were normal but 3 years later serum calcium levels rose again. A 99mTc-sestamibi scan showed increased uptake in the low right area compatible with adenoma. After biochemical test showing probable insulinoma, somatostatin receptor scintigraphy showed a focal captation in head and body of pancreas. MRI found two nodules in the same localization. An antral gastrectomy, total pancreatoduodenectomy, colecistectomy and truncal vagotomy was performed and histopathologic examination revealed a combination of neuroendocrine tumors: gastrinomas, somastotinomas, glucagonomas and insulinomas. After surgery she started with tingling in fingers, toes and lips, and calcium levels was 5.9 mg/dl and PTH intact 3 pg/ml. A new 99m Tc-sestamibi scan showed no captation and cervical ultrasonography was normal. Now, 2 years later, she continues with normal calcium and i-PTH levels. This report represents an unusual case of MEN 1A with association of insulinomas, gastrinomas glucagonomas and somatostatinomas in the same patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21814887     DOI: 10.1007/s11102-011-0334-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  15 in total

1.  Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.

Authors:  Roger D Klein; Sana Salih; Jesse Bessoni; Allen E Bale
Journal:  Genet Med       Date:  2005-02       Impact factor: 8.822

2.  Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry.

Authors:  Nathalie Lévy-Bohbot; Corinne Merle; Pierre Goudet; Brigitte Delemer; Alain Calender; Damien Jolly; Gérard Thiéfin; Guillaume Cadiot
Journal:  Gastroenterol Clin Biol       Date:  2004-11

Review 3.  Malignant prolactinoma: case report and review of the literature.

Authors:  Marleen Kars; Ferdinand Roelfsema; Johannes A Romijn; Alberto M Pereira
Journal:  Eur J Endocrinol       Date:  2006-10       Impact factor: 6.664

Review 4.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.

Authors:  J R Burgess; R A Harle; P Tucker; V Parameswaran; P Davies; T M Greenaway; J J Shepherd
Journal:  Arch Surg       Date:  1996-07

6.  Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.

Authors:  Susana Mascarell; David H Sarne
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 7.  Multiple endocrine neoplasia syndrome: genetic basis for clinical management.

Authors:  Tobias Carling
Journal:  Curr Opin Oncol       Date:  2005-01       Impact factor: 3.645

8.  A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.

Authors:  Thiti Snabboon; Wanee Plengpanich; Sathapakorn Siriwong; Naruemon Wisedopas; Sompongse Suwanwalaikorn; Weerapan Khovidhunkit; Vorasuk Shotelersuk
Journal:  Jpn J Clin Oncol       Date:  2005-05-13       Impact factor: 3.019

9.  Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.

Authors:  Bruno Vergès; Françoise Boureille; Pierre Goudet; Arnaud Murat; Albert Beckers; Geneviève Sassolas; Patrick Cougard; Béatrice Chambe; Corinne Montvernay; Alain Calender
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

10.  Extracapsular hematoma of the parathyroid glands.

Authors:  Philippe C J Chaffanjon; Nicolas Chavanis; Olivier Chabre; Pierre Yves Brichon
Journal:  World J Surg       Date:  2003-01       Impact factor: 3.352

View more
  1 in total

1.  Clinicopathological Data and Treatment Modalities for Pancreatic Somatostatinomas.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Eleni Papoutsi; Vasiliki Ntella; Prodromos Kanavidis; Athanasios Sioulas; Marina Tsoli; Georgios Charalampopoulos; Michail Vailas; Evangelos Felekouras
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.